Silverarc Capital Management »

Kodiak Sciences shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Kodiak Sciences (KOD) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Kodiak Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kodiak Sciences held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kodiak Sciences by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.0M 1.1M 1.80

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Kodiak Sciences

Baker Bros. Advisors
Newtyn Management
Vanguard Group
D. E. Shaw & Co
Jacobs Levy Equity Management
Board of Trustees of The Leland Stanford Junior University
Boxer Capital
Millennium Management
Bruce & Co
Dimensional Fund Advisors
Ikarian Capital
Goldman Sachs Group
Monaco Asset Management SAM
Two Sigma Investments
Two Sigma Advisers

View all funds holding Kodiak Sciences